References
- Roder BL, Wandall DA, Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT. Clinical features of Staphylococcus aureus endocarditis: a 10-y experience in Denmark. Arch Intern Med 1999; 159: 462–9
- Fowler VG, Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999; 28: 106–14
- Hsu RB, Chu SH. Impact of methicillin resistance on clinical features and outcomes of infective endocarditis due to Staphylococcus aureus. Am J Med Sci 2004; 328: 150–5
- Gentry CA, Rodvold KA, Novak RM, Hershow RC, Naderer OJ. Retrospective evaluation of therapies for Staphylococcus aureus endocarditis. Pharmacotherapy 1997; 17: 990–7
- Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991; 115: 674–80
- Sherwood M, Smith D, Crisel R, Veledar E, Lerakis S. Staphylococcus aureus endocarditis: The Grady Memorial Hospital Experience. Am J Med Sci 2006; 331: 84–7
- Chang FY, MacDonald BB, Peacock JE, Jr, Musher DM, Triplett P, Mylotte JM, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine 2003; 82: 322–32
- Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633–8
- Wang JT, Chang SC, Ko WJ, Chang YY, Chen ML, Pan HJ, et al. A hospital-acquired outbreak of methicillin-resistant Staphylococcus aureus infection initiated by a surgeon carrier. J Hosp Infect 2001; 47: 104–9
- Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128–40
- Stein DS, Nelson KE. Endocarditis due to nutritionally deficient streptococci: therapeutic dilemma. Rev Infect Dis 1987; 9: 908–16
- Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R, National Nosocomial Infections Surveillance System. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992–2003. Clin Infect Dis 2006;42:389–91.
- Hsueh PR, Chen ML, Sun CC, Chen WH, Pan HJ, Yang LS, et al. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981–1999. Emerg Infect Dis 2002; 8: 63–8
- Wang JT, Chen YC, Yang TL, Chang SC. Molecular epidemiology and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in Taiwan. Diagn Microbiol Infect Dis 2002; 42: 199–203
- Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998; 158: 182–9
- Chesi G, Colli A, Mestres CA, Gambarati G, Boni F, Gherli T. Multiresistant-MRSA tricuspid valve infective endocarditis with ancient osteomyelitis locus. BMC Infect Dis 2006; 6: 124
- Ozkurt Z, Erkut B, Kadanali A, Ates A, Yekeler I. Nosocomial methicillin-resistant Staphylococcus aureus endocarditis with splenic abscess in a pregnant woman. Jpn J Infect Dis 2005; 58: 323–5
- Demey HE, Eycken M, Vandermast M, Bossaert LL. Purulent pericarditis due to methicillin-resistant Staphylococcus aureus. A case report. Acta Cardiol 1991; 46: 485–91
- Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother 1996; 37: 209–22
- Sipahi OR, Arda B, Yurtseven T, Sipahi H, Ozgiray E, Suntur BM, Ulusoy S. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis. Int J Antimicrob Agents 2005; 26: 412–5
- Arda B, Yamazhan T, Sipahi OR, Islekel S, Buke C, Ulusoy S. Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases. Int J Antimicrob Agents 2005; 25: 414–8
- May J, Shannon K, King A, French G. Glycopeptide tolerance in Staphylococcus aureus. J Antimicrob Chemother 1998; 42: 189–97
- Segreti JA, Crank CW, Finney MS. Daptomycin for the treatment of Gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Pharmacotherapy 2006; 26: 347–52
- Nathani N, Iles P, Elliott TS. Successful treatment of MRSA native valve endocarditis with oral linezolid therapy: a case report. J Infect 2005; 51: 213–5
- Bassetti M, Di Biagio A, Del Bono V, Cenderello G, Bassetti D. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid. Int J Antimicrob Agents 2004; 24: 83–4